Revolution Medicines Inc (NASDAQ:RVMD) Stock Price Settled at $32.23: What’s Resulting?

Piper Sandler raised the price target for the Revolution Medicines Inc (NASDAQ:RVMD) stock to “an Overweight”. The rating was released on March 11, 2024, according to finviz. We previously noted in another research note published on January 05, 2024 by BofA Securities that upgraded the stock from a Neutral to a Buy with a price target of $34 for RVMD stock. The research report from Wedbush has initiated the stock to Outperform, with a price target set at $41. The stock was initiated by Raymond James, who disclosed in a research note on November 16, 2023, to Outperform and set the price objective to $30. In their research brief published February 28, 2023, JP Morgan analysts upgraded the Revolution Medicines Inc stock from Neutral to Overweight with a price target of $38.

Historical Earnings Surprises and Revenue Forecasts

Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report as stock price to increase when earnings exceed market expectations and progressively decrease when earnings do not meet expectations. The firm reported an earnings per share (EPS) of -$1.14 during the last quarter as opposed to a consensus estimate of -$0.88, which indicates the company missed its estimate by -$0.26, which implies that the company surprised the market by -29.50%. It appears that the average earnings per share estimate for the current quarter (ending in Mar 2024) is -$0.74. This is an average of 10 analysts’ earnings, where the high earnings per share estimate is -$0.67 and the low earnings per share estimate is -$0.85.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The latest trade, Performances and Moving Averages give us the following Picture

The firm’s stock price fluctuated -0.62% within the last five trades and 7.58% within the last 30 trades, which was a significant change from the beginning of this year. Despite the fact that the share price increased 11.52% in the last 6 months and 9.96% was added to its value over the previous 3 months. RVMD stock is trading at a margin of 3.11%, 7.98% and 16.85% apart from the 20-Day, 50-Day and 200-Day Simple Moving Average prices.

As of the close of trading, RVMD deals in the Healthcare domain. The stock is trading -9.47 percent below its 52-week high and 108.74 percent above its 52-week low. For example, looking both at the price and the high and low measurements of 52 weeks will give you a clearer picture of the direction the price is heading. The firm’s Weighted Alpha is 77.7. A positive weighted alpha indicates the firm has done well over the course of the year, whereas one below 0 indicates that the firm has done poorly.

What Does Revolution Medicines Inc’s Profitability and Valuation Ratios Tell Us About the Stock?

With regard to the profitability of the company, the operating margin is currently at -4207.12 percent and the profit margin is -3768.28 percent, and the company has reported a gross margin of 19.61 percent. The profit margin, also known as the revenue ratio or gross profit ratio, is an efficiency figure used to estimate the business’s profitability by comparing net income and sales. The higher the number, the more profits are generated for the company and vice versa.

The stock’s market cap achieved a total value of $5.31 billion as of the last trading session. Market capitalization is the total value of all outstanding shares of a corporation and it is used to measure a company’s market value. Forward price-to-earnings is calculated using predicted earnings for the next financial year’s P/E determination. The stock has achieved an effective Price-to-Sales Ratio of 458.37 that mirrors the cost to be found for sales by the market. The firm managed a Price-to-Book ratio of 2.91, which equates the market value of a stock with its book value.

Is Insider Trading a Real Thing?

Almost all investors and traders prefer to invest in shares controlled by the management of a corporation as a management company will be more likely to run the business itself and to never conduct things against the management’s desires and will always try to do what is best for their shareholders. Currently, 17.17 percent of Revolution Medicines Inc shares are owned by insiders, and 78.97 percent are held by financial institutions. Cislini Jeff, the General Counsel at Revolution Medicines Inc (RVMD) has sold 1,500 shares of firm on Mar 27 ’24 at a price of $30.99 against the total amount of $46481.0. In another inside trade, GOLDSMITH MARK A, of Revolution Medicines Inc (NASDAQ:RVMD) sold 5,788 shares of the firm on Mar 18 ’24 for a total worth of $0.18 million at a price of $31.58. An inside trade which took place on Mar 18 ’24, Chief Operating Officer of Revolution Medicines Inc Horn Margaret A sold 2,914 shares of firm against total price of $92033.0 at the cost of $31.58 per share.

Most Popular

Related Posts